VHL and neoplasm: Corroborating the in vitro results, the 786-O cells with a restored expression of either WT or L169P VHL exhibited slower growth rates in vivo, resulting in a significantly lower terminal tumor size and weight compared to the parental 786-O xenografts (Figure 4C,D).